CY1113261T1 - Διαδικασια για την παρασκευη εναντιομερικως καθαρων 1- υποκατεστημενων-3-αμινοαλκοολων - Google Patents

Διαδικασια για την παρασκευη εναντιομερικως καθαρων 1- υποκατεστημενων-3-αμινοαλκοολων

Info

Publication number
CY1113261T1
CY1113261T1 CY20121100937T CY121100937T CY1113261T1 CY 1113261 T1 CY1113261 T1 CY 1113261T1 CY 20121100937 T CY20121100937 T CY 20121100937T CY 121100937 T CY121100937 T CY 121100937T CY 1113261 T1 CY1113261 T1 CY 1113261T1
Authority
CY
Cyprus
Prior art keywords
aminocoloses
substitutes
procedure
amino
salts
Prior art date
Application number
CY20121100937T
Other languages
English (en)
Inventor
Dominique Michel
Hanspeter Mettler
John Mcgarrity
Original Assignee
Lonza Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP04003809A external-priority patent/EP1566383A1/en
Application filed by Lonza Ag filed Critical Lonza Ag
Publication of CY1113261T1 publication Critical patent/CY1113261T1/el

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/20Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/18Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/22Nitrogen atoms not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/22Radicals substituted by doubly bound hetero atoms, or by two hetero atoms other than halogen singly bound to the same carbon atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07Optical isomers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Furan Compounds (AREA)

Abstract

Παρέχεται μία διαδικασία για την παρασκευή εναντιομερικώς καθαρών 1-υποκατεστημένων-3-αμινοαλκοολών, ειδικότερα της S)-(-)- και (R)-(+)-3-Ν-μεθυλαμινο-1-(2-θειενυλο)-1-προπανόλης, με ασύμμετρη υδρογόνωση αλάτων ενός καρβοξυλικού οξέος με μια αμινοκετόνη του τύπου (II), όπου R1 επιλέγεται από την ομάδα η οποία αποτελείται από 2-θειενύλιο, 2-φουρανύλιο και φαινύλιο, έκαστο κατ' επιλογή υποκατεστημένο με ένα ή περισσότερα άτομα αλογόνου και/ή μία ή περισσότερες C1-4 αλκοξυ ομάδες, και όπου R2 είναι C1-4 αλκύλιο ή φαινύλιο, έκαστο κατ' επιλογή υποκατεστημένο με ένα ή περισσότερα άτομα αλογόνου και/ή μία ή περισσότερες C1-4 αλκυλικές ή C1-4-αλκοξυ ομάδες, και όπου οι αντίστοιχες αμινοαλκοόλες λαμβάνονται με επακόλουθη υδρόλυση των αλάτων τους. Επιπροσθέτως παρέχονται άλατα ενός καρβοξυλικού οξέος με τις εν λόγω αμινοκετόνες και τις αμινοαλκοόλες που λαμβάνονται με ασύμμετρη υδρογόνωση των εν λόγω αμινοκετονών, αντίστοιχα.
CY20121100937T 2004-02-19 2012-10-10 Διαδικασια για την παρασκευη εναντιομερικως καθαρων 1- υποκατεστημενων-3-αμινοαλκοολων CY1113261T1 (el)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP04003809A EP1566383A1 (en) 2004-02-19 2004-02-19 Process for the preparation of enantiomerically pure 1-substituted-3-aminoalcohols
EP04010043 2004-04-28
EP05715425A EP1720852B1 (en) 2004-02-19 2005-02-21 Process for the preparation of enantiomerically pure 1-substituted-3-aminoalcohols

Publications (1)

Publication Number Publication Date
CY1113261T1 true CY1113261T1 (el) 2016-04-13

Family

ID=34889010

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20121100937T CY1113261T1 (el) 2004-02-19 2012-10-10 Διαδικασια για την παρασκευη εναντιομερικως καθαρων 1- υποκατεστημενων-3-αμινοαλκοολων

Country Status (20)

Country Link
US (3) US7973182B2 (el)
EP (1) EP1720852B1 (el)
JP (2) JP2007523124A (el)
KR (1) KR101160502B1 (el)
CN (1) CN102627572A (el)
AU (1) AU2005215906C1 (el)
BR (1) BRPI0506796A (el)
CA (1) CA2556891C (el)
CY (1) CY1113261T1 (el)
DK (1) DK1720852T3 (el)
EA (1) EA200601513A1 (el)
ES (1) ES2391399T3 (el)
IL (1) IL177561A (el)
NO (1) NO20064017L (el)
NZ (1) NZ549381A (el)
PL (1) PL1720852T3 (el)
PT (1) PT1720852E (el)
SG (1) SG135196A1 (el)
SI (1) SI1720852T1 (el)
WO (1) WO2005080370A1 (el)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1720852B1 (en) 2004-02-19 2012-07-11 Lonza AG Process for the preparation of enantiomerically pure 1-substituted-3-aminoalcohols
KR20070104942A (ko) * 2005-02-21 2007-10-29 론자 아게 거울상적으로 순수한 1-치환-3-아미노알코올의 제조 방법
CA2656128A1 (en) 2006-07-03 2008-01-10 Ranbaxy Laboratories Limited Process for the preparation of enantiomerically pure salts of n-methyl-3(1-naphthaleneoxy)-3-(2-thienyl)propanamine
US8288141B2 (en) 2008-08-27 2012-10-16 Codexis, Inc. Ketoreductase polypeptides for the production of 3-aryl-3-hydroxypropanamine from a 3-aryl-3-ketopropanamine
ES2560459T3 (es) 2008-08-27 2016-02-19 Codexis, Inc. Polipéptidos cetorreductasa para la producción de una 3-aril-3-hidroxipropanamina a partir de una 3-aril-3-cetopropanamina
SI2558455T1 (sl) 2010-04-13 2017-12-29 Krka, D.D., Novo Mesto Sinteza duloksetina in/ali njegovih farmacevtsko sprejemljivih soli
CN104056663B (zh) * 2013-03-22 2016-12-28 上海交通大学 一种面手性双反应中心钌催化剂及其合成与应用
CN110054563A (zh) * 2019-06-10 2019-07-26 江西隆莱生物制药有限公司 丁内酯类化合物的制备方法及其中间体
CN111793056A (zh) * 2020-07-27 2020-10-20 广州康瑞泰药业有限公司 一种度洛西汀中间体的制备方法

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3031248A1 (de) 1980-08-19 1982-04-01 Ruhrchemie Ag, 4200 Oberhausen Verfahren zur herstellung von 3-dimethylamino-2,2-dimethylpropanal
US5362866A (en) 1983-09-02 1994-11-08 Molecular Biosystems, Inc. Oligonucleotide polymeric support system with an oxidation cleavable link
KR880007433A (ko) * 1986-12-22 1988-08-27 메리 앤 터커 3-아릴옥시-3-치환된 프로판아민
US4948813A (en) 1987-11-30 1990-08-14 E. I. Du Pont De Nemours And Company Benzylketone phospholipase A2 inhibitors
CA2042346A1 (en) * 1990-05-17 1991-11-18 Michael Alexander Staszak Chiral synthesis of 1-aryl-3-aminopropan-1-ols
JPH0570412A (ja) * 1991-09-13 1993-03-23 Fuji Yakuhin Kogyo Kk 光学活性なβ−アミノアルコールの製造方法
US5491234A (en) * 1992-03-30 1996-02-13 Pfizer Inc. Pyrimidine derivatives for enhancing antitumor activity
ES2130321T3 (es) 1993-10-08 1999-07-01 Hoffmann La Roche Compuestos de fosforo opticamente activos.
US5362886A (en) 1993-10-12 1994-11-08 Eli Lilly And Company Asymmetric synthesis
IT1270082B (it) * 1994-07-12 1997-04-28 Univ Degli Studi Milano Difosfine eteroaromatiche come leganti chirali, complessi tra dette difosfine e metalli di transizione ed impiego di detti complessi come catalizzatori chirali
US6008412A (en) * 1997-10-14 1999-12-28 Eli Lilly And Company Process to make chiral compounds
TW514634B (en) * 1997-10-14 2002-12-21 Lilly Co Eli Process to make chiral compounds
US6162929A (en) 1997-12-23 2000-12-19 Hoffmann-La Roche Inc. Process for the manufacture of bisphosphine oxide and bisphosphonate compounds
JP3549390B2 (ja) 1998-03-23 2004-08-04 高砂香料工業株式会社 ルテニウム−ホスフィン錯体及びその製造方法
EP0955303B1 (en) 1998-05-08 2006-11-08 Takasago International Corporation Ruthenium-iodo-optically active phosphine complex
FR2816946B1 (fr) 2000-11-17 2004-04-02 Ppg Sipsy Diphosphines chirales dissymetriques, leurs utilisations pour la preparation de complexes diphosphino-metalliques, et les complexes diphosphino-metalliques ainsi obtenus
DE10207586A1 (de) * 2002-02-22 2003-09-11 Degussa Herstellung von N-Methyl-3-hydroxy-3-(2-thienyl)propanamin über neue carbamatgruppenhaltige Thiophenderivate als Zwischenprodukte
FR2841899A1 (fr) 2002-07-05 2004-01-09 Ppg Sipsy Procede de resolution asymetrique d'un racemique faisant intervenir l'acide diprogulique et utilisation dudit acide comme agent de resolution asymetrique
WO2004005307A1 (en) * 2002-07-09 2004-01-15 Lonza Ag Process for the preparation of optically active 3-n-methylamino-1-(2-thienyl)-1-propanol
ES2293029T3 (es) * 2002-07-09 2008-03-16 Lonza Ag Proceso para la preparacion de beta-amino alcoholes n-monosustituidos.
EP1720852B1 (en) 2004-02-19 2012-07-11 Lonza AG Process for the preparation of enantiomerically pure 1-substituted-3-aminoalcohols

Also Published As

Publication number Publication date
WO2005080370A1 (en) 2005-09-01
ES2391399T3 (es) 2012-11-26
EP1720852B1 (en) 2012-07-11
NO20064017L (no) 2006-09-15
CA2556891A1 (en) 2005-09-01
SI1720852T1 (sl) 2012-11-30
JP2007523124A (ja) 2007-08-16
US20110207946A1 (en) 2011-08-25
EP1720852A1 (en) 2006-11-15
IL177561A (en) 2011-12-29
CA2556891C (en) 2012-12-18
AU2005215906B2 (en) 2011-08-18
PL1720852T3 (pl) 2012-12-31
KR20070009587A (ko) 2007-01-18
EA200601513A1 (ru) 2007-02-27
US20110207945A1 (en) 2011-08-25
IL177561A0 (en) 2006-12-10
JP2012229223A (ja) 2012-11-22
US8198468B2 (en) 2012-06-12
NZ549381A (en) 2010-05-28
US20080154047A1 (en) 2008-06-26
AU2005215906A1 (en) 2005-09-01
US8193380B2 (en) 2012-06-05
KR101160502B1 (ko) 2012-06-28
US7973182B2 (en) 2011-07-05
DK1720852T3 (da) 2012-10-22
PT1720852E (pt) 2012-10-22
AU2005215906C1 (en) 2012-03-01
BRPI0506796A (pt) 2007-05-22
CN102627572A (zh) 2012-08-08
SG135196A1 (en) 2007-09-28

Similar Documents

Publication Publication Date Title
CY1113261T1 (el) Διαδικασια για την παρασκευη εναντιομερικως καθαρων 1- υποκατεστημενων-3-αμινοαλκοολων
DE602005023185D1 (de) Prodrugs mit neuen biospaltbaren verbindern
ECSP055696A (es) Acetil 2-hidroxi-1, 3-diaminoalcanos
PE20040636A1 (es) Ester de 2'-c-metil-3'-o-l-valina de ribofuranosilcitidina
ATE468317T1 (de) Herstellung von 1,3-diphenylprop-2-en-1- onderivaten
CY1108529T1 (el) Νεα αζαδικυκλικα παραγωγα, μεθοδος παρασκευης τους και φαρμακευτικες συνθεσεις που τα περιεχουν
DE502005001841D1 (de) Verfahren zur herstellung von 1,4-diphenylazetidinon-derivaten
ECSP045497A (es) "difenilazetidinonas sustituidas con grupos acidos, metodo para su producción, medicamentos que comprenden dichos compuestos y su uso"
WO2006027798A3 (en) A process for preparation of an antidepressant compound
MA29416B1 (fr) Inhibiteurs d'age
BRPI0409105A (pt) análogos de quinobenzoxazina substituìdos
DE602005014280D1 (de) Verfahren zur herstellung von ä1,4,5ü-oxadiazepinderivaten
DE602005011814D1 (de) Verfahren zur herstellung von enantiomerreinen 1,1'-spirobiindan-6,6'-diol-derivaten
ATE378326T1 (de) Herstellung und verwendung von 3-methylamino-1-(2-thienyl)-1-propanon
DE50212728D1 (de) Verfahren zur herstellung von 2-azetidinonderivaten
ATE424892T1 (de) Verfahren zur herstellung von derivaten des 4a,5, 9,10,11,12-hexahydrobenzofuro ä3a,3,2üä 2 ü- benzazepins
DE602006015458D1 (de) Verfahren zur herstellung eines carbonsäureamidderivats
ATE424195T1 (de) Verwendung von 2-amino-1,3-propandiolderivaten zur herstellung eines medikaments zur behandlung von bestimmten schmerzen
RS50722B (sr) 2-okso-1,2,4,5-tetrahidro-1,3-benzdiazepin-3-il-piperidini korišćeni u vidu cgrp antagonista
DE602004004677D1 (de) Verfahren zur herstellung substituierter 5-amino-pyrazolo-ä4,3-eü-1,2,4-triazoloä1,5-cüpyrimidine
DE60007668D1 (de) Verwendung lebender abgeschwächter Bakterien zur Herstellung eines submukosalen Impstoffes
BR0110490B1 (pt) agentes de tingimento contendo derivados de n-heteroarilmetil-m-fenilenodiamina para fibras de queratina bem como novos derivados de n-heteroarilmetil-m-fenilenodiamina.
DE502004010100D1 (de) Verfahren zur Herstellung von 9,10-Dihydro-9-oxa-10-organyl-oxyphosphaphenanthren-10-oxid oder -thion und an den Phenylgruppen substituierten Derivativen desselben
ATE416182T1 (de) Kristalline form von risedronat-mononatrium
DE60323748D1 (de) 1,3-diaza-dibenzoazulene als inhibitoren der produfür deren herstellung